Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Differential effect of corticosteroid treatment on Influenza, SARS, MERS, and SARS-CoV-2 patients: A meta-analysis and systematic review

Sobur Ali, Salman Zahir Uddin, Md. Nayem Dewan, M Moniruzzaman, Mir Himayet Kabir, Mohammad Rafiqul Islam, Hossain Monir, Shanewaz Hossan, Tanvir Noor Nafiz, Rumana Rashid, View ORCID ProfileKhan Mohammad Imran
doi: https://doi.org/10.1101/2021.03.22.21254104
Sobur Ali
1Department of Microbiology, University of Dhaka, Dhaka-1000, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salman Zahir Uddin
1Department of Microbiology, University of Dhaka, Dhaka-1000, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Md. Nayem Dewan
2Institute of Statistical Research and Training, University of Dhaka, Dhaka-1000, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Moniruzzaman
1Department of Microbiology, University of Dhaka, Dhaka-1000, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mir Himayet Kabir
3Department of Medical Microbiology and Immunology, School of Medicine and Life Science, University of Toledo, 2801 Bancroft St, Toledo, OH 43606
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Rafiqul Islam
4Department of Chemistry, Jahangirnagar University, Savar, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hossain Monir
1Department of Microbiology, University of Dhaka, Dhaka-1000, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shanewaz Hossan
5Department of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanvir Noor Nafiz
1Department of Microbiology, University of Dhaka, Dhaka-1000, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rumana Rashid
6Economics Discipline, Social Science School, Khulna University, Khulna, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khan Mohammad Imran
7Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA 24061
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Khan Mohammad Imran
  • For correspondence: email-imrankhan@vt.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Corticosteroid has been used to manage inflammation caused by many diseases including respiratory viral infections. Many articles are available to support the good and bad side of this steroid use but remain inconclusive. To find some evidence about the safety of the drug, we investigated the effect of corticosteroids on the mortality of patients with respiratory viral infections including SARS-CoV-2, SARS, MERS, and Influenza.

Method We searched articles in PubMed, Scopus, Cochrane, Medline, Google Scholar, and Web of Science records using keywords “corticosteroid” or “viral infection” or “patients” or “control study”. Mortality was the primary outcome.

Result Our selected 24 studies involving 16633 patients were pooled in our meta-analysis. Corticosteroid use and overall mortality were not significantly associated (P=0.176), but in subgroup analysis, corticosteroid use was significantly associated with lower mortality in the case of SARS (P=0.003) but was not significantly associated with mortality for Influenza (H1N1) (P=0.260) and SARS-CoV-2 (P=0.554). Further analysis using study types of SARS-CoV-2, we found that corticosteroid use was not significantly associated with mortality in the case of retrospective cohort studies (P=0.256) but was significantly associated with lower mortality in the case of randomized control trials (P=0.005). Our findings uncover how the outcome of particular drug treatment for different diseases with comparable pathogenesis may not be similar and, RCTs are sometimes required for robust outcome data.

Conclusion At the beginning of the COVID-19 pandemic, data of corticosteroid use from other viral infections along with COVID-19 observational and retrospective cohort studies created confusion of its effect, but randomized control trials showed that corticosteroid can be used to treat COVID-19 patients.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The author(s) disclosed that this research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This work did not require ethical approval as it does not involve any human or animal experiment.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data will be made available upon request.

  • Abbreviations

    RCT
    Randomized Control Trial
    RCS
    Retrospective Cohort Study
    SARS
    Severe acute respiratory syndrome
    MERS
    Middle East Respiratory Syndrome
    SARS-CoV-2
    Severe Acute Respiratory Syndrome Coronavirus 2
    H1N1
    Hemagglutinin (H) and Neuraminidase (N)
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
    Back to top
    PreviousNext
    Posted March 26, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Differential effect of corticosteroid treatment on Influenza, SARS, MERS, and SARS-CoV-2 patients: A meta-analysis and systematic review
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Differential effect of corticosteroid treatment on Influenza, SARS, MERS, and SARS-CoV-2 patients: A meta-analysis and systematic review
    Sobur Ali, Salman Zahir Uddin, Md. Nayem Dewan, M Moniruzzaman, Mir Himayet Kabir, Mohammad Rafiqul Islam, Hossain Monir, Shanewaz Hossan, Tanvir Noor Nafiz, Rumana Rashid, Khan Mohammad Imran
    medRxiv 2021.03.22.21254104; doi: https://doi.org/10.1101/2021.03.22.21254104
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Differential effect of corticosteroid treatment on Influenza, SARS, MERS, and SARS-CoV-2 patients: A meta-analysis and systematic review
    Sobur Ali, Salman Zahir Uddin, Md. Nayem Dewan, M Moniruzzaman, Mir Himayet Kabir, Mohammad Rafiqul Islam, Hossain Monir, Shanewaz Hossan, Tanvir Noor Nafiz, Rumana Rashid, Khan Mohammad Imran
    medRxiv 2021.03.22.21254104; doi: https://doi.org/10.1101/2021.03.22.21254104

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Intensive Care and Critical Care Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (230)
    • Allergy and Immunology (507)
    • Anesthesia (111)
    • Cardiovascular Medicine (1264)
    • Dentistry and Oral Medicine (207)
    • Dermatology (148)
    • Emergency Medicine (283)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
    • Epidemiology (10056)
    • Forensic Medicine (5)
    • Gastroenterology (502)
    • Genetic and Genomic Medicine (2486)
    • Geriatric Medicine (240)
    • Health Economics (482)
    • Health Informatics (1653)
    • Health Policy (757)
    • Health Systems and Quality Improvement (638)
    • Hematology (250)
    • HIV/AIDS (538)
    • Infectious Diseases (except HIV/AIDS) (11896)
    • Intensive Care and Critical Care Medicine (627)
    • Medical Education (255)
    • Medical Ethics (75)
    • Nephrology (269)
    • Neurology (2304)
    • Nursing (140)
    • Nutrition (354)
    • Obstetrics and Gynecology (458)
    • Occupational and Environmental Health (537)
    • Oncology (1259)
    • Ophthalmology (377)
    • Orthopedics (134)
    • Otolaryngology (226)
    • Pain Medicine (158)
    • Palliative Medicine (50)
    • Pathology (326)
    • Pediatrics (737)
    • Pharmacology and Therapeutics (315)
    • Primary Care Research (282)
    • Psychiatry and Clinical Psychology (2295)
    • Public and Global Health (4850)
    • Radiology and Imaging (846)
    • Rehabilitation Medicine and Physical Therapy (493)
    • Respiratory Medicine (657)
    • Rheumatology (289)
    • Sexual and Reproductive Health (241)
    • Sports Medicine (228)
    • Surgery (273)
    • Toxicology (44)
    • Transplantation (131)
    • Urology (100)